Federal Trade Commission accuses three drug middlemen of …
Sep 21, 2024 · The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
Federal Trade Commission sues largest drug middlemen for
Sep 20, 2024 · CNN — The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that...
FTC Sues Prescription Drug Middlemen for Artificially Inflating …
Sep 20, 2024 · The FTC alleges that the three PBMs created a perverse drug rebate system that prioritizes high rebates from drug manufacturers, leading to artificially inflated insulin list prices.
FTC sues drug middlemen for allegedly inflating insulin prices
Sep 20, 2024 · The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen use practices that boost their profits while...
Drug middlemen illegally drive up the cost of insulin, FTC says
Sep 20, 2024 · Federal regulators are accusing the country's three largest pharmacy benefit managers of illegally driving up the cost of insulin in the U.S., while making it harder for patients to obtain...
ANALYSIS: FTC to Expand Drug Middlemen Price Hike Fight in 2025
2 days ago · The Bloomberg Law 2025 series previews the themes and topics that our legal analysts will be watching closely in 2025. Our Litigation analyses examine developments inside and outside the courtroom that will shape the course of law in the year ahead. Non-subscribers can access the articles in the series here. The Federal Trade Commission in ...
FTC says prescription middlemen are squeezing Main Street ... - CBS News
Jul 9, 2024 · Prescription drug middlemen — also known as pharmacy benefit managers — are lining their pockets by inflating drug prices, including overcharging cancer patients, the Federal Trade Commission...
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
Sep 20, 2024 · The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of inflating insulin prices and...
House Oversight Panel Blames Drug Middlemen for Higher Prices
Jul 23, 2024 · Drug benefits middlemen engage in anticompetitive practices to push patients toward higher-cost medicines and boost their profits, according to a Congressional report released Tuesday. The...
FTC Accuses Drug Middlemen of Inflating Insulin Prices
Sep 20, 2024 · The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin. The FTC on Friday filed an ...
- Some results have been removed